Загрузка...
Low-dose cytosine arabinoside-induced syptomatic bradycardia in a patient with acute myeloid leukemia
Cytosine arabinoside (Ara-C) is one of the critical agents for the treatment of acute myeloid leukemia (AML). The toxicity profile of Ara-C is highly dependent on the dose and schedule of administration. Cardiologic complications associated with Ara-C are rare. These side effects were reported with...
Сохранить в:
| Опубликовано в: : | J Cardiol Cases |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Japanese College of Cardiology
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6281503/ https://ncbi.nlm.nih.gov/pubmed/30546756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2013.06.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|